Target Group (OTCQB: CBDY) has announced the completion of its cannabis production facility in Norfolk County.
The 44,000-sq.-ft. facility will be managed by the company’s subsidiary Canary Rx. Work on the external and structural upgrade of the facility was started in September 2017, following by an interior build-out in July 2018.
Facility to Cultivate Organic Cannabis
Target Group says that the facility is designed “by cannabis growers for cannabis growers” and is engineered to meet Health Canada’s quality and security standards.
The production area is equipped with latest environmental control technology, custom-built to regulate eight 2,200-sq.-ft. flower rooms as well as vegetative, breeding, testing, and curing spaces.
Situated in Ontario’s Garden, the facility lies nestled amongst the shores of Lake Erie in an agricultural community. The production space is projected to produce 3,600kg cannabis per year.
Canary Rx is in the final stages of obtaining a license to cultivate under the Cannabis Act. The company’s team will cultivate premium, organic cannabis.
Target Group is a cannabis acquisition company. It owns and operates Canary Rx, a final-stage Canadian cannabis license applicant, and CannaKorp, the maker of the pod-based Wisp Vapor technology.
Target Group is working to expand its global operations to build an international network of manufacturing, distribution, production, and sales operations.